Cited by — A phase
<scp>IIa</scp>
study of the anti‐
<scp>PD</scp>
‐
<scp>L1</scp>
antibody avelumab in relapsed/refractory
<scp>PTCL</scp>
: The
<scp>AVAIL</scp>
‐T trial | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite A phase
<scp>IIa</scp>
study of the anti‐
<scp>PD</scp>
‐
<scp>L1</scp>
antibody avelumab in relapsed/refractory
<scp>PTCL</scp>
: The
<scp>AVAIL</scp>
‐T trial.
No admitted local citation edges point to this work yet.
